Xiufeng Pang

3.9k total citations · 1 hit paper
59 papers, 2.8k citations indexed

About

Xiufeng Pang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiufeng Pang has authored 59 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 20 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Xiufeng Pang's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer-related Molecular Pathways (5 papers). Xiufeng Pang is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer-related Molecular Pathways (5 papers). Xiufeng Pang collaborates with scholars based in China, United States and United Kingdom. Xiufeng Pang's co-authors include Mingyao Liu, Zhengfang Yi, Jieqiong Wang, Weijing Qu, Bharat B. Aggarwal, Yihua Chen, Tingfang Yi, Sung‐Gook Cho, Bokyung Sung and Ying Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xiufeng Pang

59 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma

2019 287 citations Kewen Hu, Kun Li et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Xiufeng Pang

Since Specialization

Citations

This map shows the geographic impact of Xiufeng Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiufeng Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiufeng Pang more than expected).

Fields of papers citing papers by Xiufeng Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiufeng Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiufeng Pang. The network helps show where Xiufeng Pang may publish in the future.

Co-authorship network of co-authors of Xiufeng Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiufeng Pang. A scholar is included among the top collaborators of Xiufeng Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiufeng Pang. Xiufeng Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells 2025 ·International Immunopharmacology ·Jing Zhang, (unknown), Jun Yang, (unknown), Weijun Zeng, Xinyi Li, (unknown), (unknown), Xiufeng Pang, (unknown), (unknown)	1
2	Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model 2025 ·Journal of Nanobiotechnology ·Yufei Wu, (unknown), (unknown), Guilian Yang, Cong Wang, Xinyi Ye, Yun Chen, Xiufeng Pang, (unknown), Zijun Wang, Yuxuan Wu	1
3	Loss of PHF8 induces a viral mimicry response by activating endogenous retrotransposons 2023 ·Nature Communications ·Yanan Liu, (unknown), (unknown), Kun Yuan, Guangliang Hong, (unknown), (unknown), Na Li, Dali Li, Jiemin Wong, Jiekai Chen, Mingyao Liu, Jiangping He, Xiufeng Pang	16
4	Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance 2023 ·Journal of Medicinal Chemistry ·Peng He, (unknown), (unknown), Yue Sun, (unknown), (unknown), (unknown), Xueli Zhang, Mingyao Liu, Xiufeng Pang, Yihua Chen	16
5	Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer 2023 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cun Wang, Xueli Zhang, Xiufeng Pang	39
6	Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-d]pyrimidine Analogues Bearing Deuterated Methylene Linkers as Potent KRAS^G12D Inhibitors 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Jing Ma, (unknown), (unknown), Jian Zhang, Chunyong Ding, Xiufeng Pang, Ao Zhang	9
7	BCL6 confers KRAS-mutant non–small-cell lung cancer resistance to BET inhibitors 2021 ·Journal of Clinical Investigation ·Jiawei Guo, Yanan Liu, Jing Lv, Bin Zou, Zhi Chen, Kun Li, (unknown), Zhenyu Cai, Lai Wei, Mingyao Liu, Xiufeng Pang	33
8	Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth 2020 ·Journal of Medicinal Chemistry ·Weikai Guo, (unknown), Qiansen Zhang, (unknown), (unknown), (unknown), Peng He, (unknown), Shifen Xu, Xiufeng Pang, Mingyao Liu, Zhengfang Yi, Yihua Chen	25
9	Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study 2020 ·Journal of Cancer Research and Clinical Oncology ·Haizhen Zhu, Chunju Fang, Yi Guo, Qi Zhang, (unknown), (unknown), Guangpeng Chen, Xiufeng Pang, Jianjun Hu, Jianguo Sun, Zhengtang Chen	12
10	Blocking STAT3 by pyrvinium pamoate causes metabolic lethality in KRAS-mutant lung cancer 2020 ·Biochemical Pharmacology ·(unknown), Wenhao Jiang, Yanan Liu, Wanfeng Huang, Kewen Hu, Kun Li, Jing Chen, Chengbin Ma, Zhenliang Sun, Xiufeng Pang	18
11	Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways 2020 ·Life Sciences ·Jing Chen, Na Li, (unknown), Jun Ling, Wenjun Yang, Xiufeng Pang, Tao Li	44
12	Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma breakdown → 2019 ·Journal of Clinical Investigation ·Kewen Hu, Kun Li, Jing Lv, Jie Feng, Jing Chen, Haigang Wu, Feixiong Cheng, Wenhao Jiang, Jieqiong Wang, Haixiang Pei, Paul J. Chiao, Zhenyu Cai, Yihua Chen, Mingyao Liu, Xiufeng Pang	287
13	Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles 2018 ·Drug Delivery ·Haizhen Zhu, Jing Hou, Yi Guo, Xin Liu, Feilong Jiang, Guangpeng Chen, Xiufeng Pang, Jianguo Sun, Zhengtang Chen	18
14	Genomic landscape of gastric cancer: molecular classification and potential targets 2016 ·Science China Life Sciences ·Jiawei Guo, Weiwei Yu, Hui Su, Xiufeng Pang	19
15	Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer 2016 ·Scientific Reports ·Jing Chen, Jiawei Guo, Zhi Chen, Jieqiong Wang, Mingyao Liu, Xiufeng Pang	26
16	Sporoderm-Broken Spores of Ganoderma lucidum Inhibit the Growth of Lung Cancer: Involvement of the Akt/mTOR Signaling Pathway 2016 ·Nutrition and Cancer ·Yali Chen, Jing Lv, Kun Li, Jing Xu, Mingyan Li, Wen Zhang, Xiufeng Pang	23
17	Small molecule 1′-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway 2014 ·Breast Cancer Research and Treatment ·Jieqiong Wang, Li Zhang, Guoliang Chen, Jing Zhang, Zhenxi Li, Weiqiang Lü, Mingyao Liu, Xiufeng Pang	29
18	Inhibitory effect of atorvastatin on AGE-induced HCAEC apoptosis by upregulating HSF-1 protein 2013 ·International Journal of Biological Macromolecules ·Ying Li, (unknown), Li Cui, (unknown), Yian Yao, Yibo Zhang, Xiufeng Pang, Jie Wang, Xuebo Liu	16
19	Inhibition of STAT3 Signaling Pathway by Nitidine Chloride Suppressed the Angiogenesis and Growth of Human Gastric Cancer 2011 ·Molecular Cancer Therapeutics ·Jing Chen, Jieqiong Wang, Lin Lei, Lijun He, Yuanyuan Wu, Li Zhang, Zhengfang Yi, Yihua Chen, Xiufeng Pang, Mingyao Liu	148
20	Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2‐mediated PI3K/Akt/mTOR signaling pathway 2010 ·Cancer Science ·Lijun He, Yuanyuan Wu, Lin Lei, Jieqiong Wang, Yougen Wu, Yihua Chen, Zhengfang Yi, Mingyao Liu, Xiufeng Pang	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact